Getting vaccinated for mpox can reduce your chance of getting mpox, and it can reduce symptoms if you do get it. Eligible New Yorkers can get the JYNNEOSTM vaccine.
We are still learning about how well the vaccine can protect you. Even after getting vaccinated, you should still take precautions, especially if you are at high risk for severe illness from mpox.
Eligibility for mpox vaccination may change as the outbreak evolves and based on vaccine supply. Vaccination is free and available regardless of immigration status or residency.
The following people are eligible to be vaccinated in NYC:
People who are breastfeeding or pregnant who are otherwise eligible for vaccination can get vaccinated. For more information, see the JYNNEOS FAQ.
If you have had mpox, then you likely have some protection against another infection and are currently not eligible to get vaccinated. Most people who were diagnosed with mpox after getting their first dose of the vaccine do not need a second dose. People who are immunocompromised should speak with their provider about whether a second dose is necessary.
People with certain allergies to vaccine ingredients or chicken or egg protein should talk to a health care provider to confirm if they should get the vaccine. If you do not have a provider, call 311 or search the NYC Health Map.
The current mpox outbreak has affected some people more than others. In addition, the risk of getting mpox is higher among people who engage in certain activities or have certain health conditions. Based on this, the JYNNEOS vaccine is recommended for people who meet the above eligibility criteria and:
You can get the JYNNEOS vaccine at the same time as most vaccines, including the flu, human papilloma virus (HPV), hepatitis A, hepatitis B, meningococcal and herpes zoster (shingles) vaccines.
You can get the JYNNEOS vaccine before, after, or at the same time as COVID-19 vaccines too. However, people at increased risk of myocarditis (inflammation of the heart), particularly males ages 12 to 39, can consider waiting four weeks between getting the JYNNEOS and COVID-19 vaccines. This is because there is a rare risk of developing myocarditis after COVID-19 vaccination. And while JYNNEOS clinical trials did not show an increased risk of myocarditis following vaccination, it is possible there is a risk.
If you know you were recently exposed to mpox, you should not delay getting the JYNNEOS vaccine, even if you recently got a COVID-19 vaccine.
For others, in deciding whether to delay getting either vaccine, consider your risk of exposure and risk of severe illness from COVID-19 and mpox. Talk to your health care provider if you have questions about timing of vaccination.
Common side effects of the JYNNEOS vaccine include tiredness, headache and muscle pain. There may also be redness, swelling, soreness and itchiness where you received the injection. Generally, the injection site side effects from an intradermal injection are worse and last longer than those from a subcutaneous injection.
Intradermal injections can result in long-term or permanent scarring, discoloration and thinning of the skin at the injection site. The risk for these types of reactions is higher for people with darker skin.
People will be asked at the vaccination site whether they have a history of keloid scars, and those who do will be offered subcutaneous administration.